Delivery Order SPE2DB22D2211-SPE2DB25FSGFA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count packages) valued at $2,831.31. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Quillichew ER 20 mg chew tablets (100 count) with a ceiling value of $1,566.46. This firm fixed-price delivery order is set to be completed by August 27, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a non-set-aside, competitively awarded procurement executed under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,407.02 to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chewable tablets (100-count) on September 23, 2025, with an ultimate completion date of September 24, 2025. The award represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units) with a ceiling value of $3,172.60. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order with an ultimate completion date of August 26, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chew tablets (100 count) on May 13, 2025, with an ultimate completion date of May 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count units) with a ceiling value of $4,234.36. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,045.00 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Quillichew ER 30 mg chewable tablets (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count units) with a ceiling value of $1,043.96. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count) with a ceiling value of $2,970.74. This is a firm fixed price delivery order with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Quillichew ER 40 mg chewable tablets (100-count units) with a ceiling value of $1,554.57. This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 9, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSGFADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Quillichew ER 30 mg chewing tablets (100-count units) with a ceiling value of $1,033.15. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The order is scheduled for ultimate completion by September 30, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime contractor serving the Defense Health Agency and other federal healthcare systems, AmerisourceBergen leverages this IDC to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The Quillichew supply under this delivery order supports DLA's medical supply chain requirements for attention-deficit/hyperactivity disorder treatment across military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/29/25 |